Rotllan, N, Camacho, M, Tondo, M, Diarte-Anazco, EMG, Canyelles, M, Mendez-Lara, KA, Benitez, S, Alonso, N, Mauricio, D, Escola-Gil, JC, Blanco-Vaca, F, Julve, J. Therapeutic Potential of Emerging NAD plus -Increasing Strategies for Cardiovascular Diseases. Antioxidants. 2021; 10(12)DOI:10.3390/antiox10121939. PMID:. IF:7.675(Q1/1D).

Rojo-Lopez, MI, Castelblanco, E, Real, J, Hernandez, M, Falguera, M, Amigo, N, Julve, J, Alonso, N, Franch-Nadal, J, Granado-Casas, M, Mauricio, D. Advanced Quantitative Lipoprotein Characteristics Do Not Relate to Healthy Dietary Patterns in Adults from a Mediterranean Area. Nutrients. 2021; 13(12)DOI:10.3390/nu13124369. PMID:34959921. IF:6.706(Q1/2D).

Bermudez-Lopez, M, Perpinan, H, Amigo, N, Castro, E, Alonso, N, Mauricio, D, Fernandez, E, Valdivielso, JM. Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients. Clinical Kidney Journal. 2021; 14(12)DOI:10.1093/ckj/sfab113. PMID:34950470. IF:5.860(Q1/2D).

Castelblanco, E, Hernandez, M, Ortega, E, Amigo, N, Real, J, Granado-Casas, M, Minambres, I, Lopez, C, Lecube, A, Bermudez-Lopez, M, Alonso, N, Julve, J, Mauricio, D. Outstanding improvement of the advanced lipoprotein profile in subjects with new-onset type 1 diabetes mellitus after achieving optimal glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2021; 182DOI:10.1016/j.diabres.2021.109145. PMID:34785302. IF:8.180(Q1/2D).